EUVIMEDEUVIMED entdecken
Crossref

RHBDD1 promotes cervical cancer progression by activating the EGFR/PI3K/AKT signaling pathway

Wei Li, Xin Liang, Xiurong Wu, Bijuan Zheng, Jie Cheng

Archives of Biochemistry and Biophysics · 2026-06 · 780 · 110777

DOI: 10.1016/j.abb.2026.110777 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2026-06. Verfasst von Wei Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Hainan General Hospital (Hainan Medical University Hainan Hospital), Haikou, Hainan, 570311, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Proto-Oncogene Proteins c-akt, Signal Transduction, Phosphatidylinositol 3-Kinases. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Although RHBDD1 has been linked to tumorigenesis, its specific role in cervical cancer (CC) remains elusive. This study investigated its oncogenic function and regulatory mechanism in CC cells. METHODS: CC cell lines were transfected with either RHBDD1-targeting or overexpression constructs. A series of functional assays, including CCK-8, colony formation, flow cytometry, and Transwell assays, were conducted to assess proliferation, cell cycle progression, apoptosis, migration, and invasion. Pharmacological modulators targeting the EGFR/PI3K/AKT pathway-gefitinib (EGFR inhibitor, 10 μM), LY294002 (PI3K inhibitor, 20 μM), and SC79 (AKT activator, 10 μM)-were applied in combination with gene manipulation. Western blotting was performed to assess pathway activation and expression of EMT-related proteins, including Snail. Co-immunoprecipitation (Co-IP) assays were conducted to evaluate the physical association between RHBDD1 and EGFR. Additionally, a xenograft mouse model was used to evaluate tumorigenic potential in vivo. RESULTS: RHBDD1 knockdown in SiHa cells markedly impaired cell growth, invasion, and EMT, as evidenced by decreased Snail expression, whereas RHBDD1 overexpression in HeLa cells enhanced malignant phenotypes and upregulated Snail. Corresponding changes in EGFR/PI3K/AKT signaling were observed: pathway activity was elevated with RHBDD1 overexpression and suppressed upon silencing. Co-IP assays confirmed a physical association between RHBDD1 and EGFR, supporting receptor-level modulation. Notably, SC79 partially reversed the suppressive effects of RHBDD1 knockdown, whereas gefitinib and LY294002 mitigated RHBDD1-induced oncogenicity. These findings were corroborated by alterations in AKT phosphorylation levels. In vivo, RHBDD1 depletion significantly reduced tumor growth, EMT marker expression, and pathway activation. CONCLUSION: RHBDD1 facilitates CC progression by promoting proliferation, EMT, migration, invasion, and tumorigenesis through activation of the EGFR/PI3K/AKT pathway, likely via direct receptor-level interaction. Targeting this regulatory node may offer a promising therapeutic approach for CC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsProto-Oncogene Proteins c-aktSignal TransductionPhosphatidylinositol 3-KinasesSerine EndopeptidasesFemaleHumansErbB ReceptorsAnimalsCell Line, TumorCell ProliferationMiceMice, NudeCell MovementDisease ProgressionMice, Inbred BALB C

Stichwörter der Autor:innen

Cervical cancerEGFR/PI3K/AKT signalingEpithelial–mesenchymal transitionRHBDD1Tumorigenesis

Substanzen

ErbB ReceptorsProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesSerine EndopeptidasesRHBDD1 protein, humanEGFR protein, human

Autor:innen und Institutionen

  • Department of Gynecology, Hainan General Hospital (Hainan Medical University Hainan Hospital), Haikou, Hainan, 570311, China.
  • Department of Gynecology, Hainan General Hospital (Hainan Medical University Hainan Hospital), Haikou, Hainan, 570311, China. Electronic address: Chenjie_CJ06@yeah.net.

Zitieren

APA

Li, W., Liang, X., Wu, X., Zheng, B., & Cheng, J. (2026). RHBDD1 promotes cervical cancer progression by activating the EGFR/PI3K/AKT signaling pathway. Archives of Biochemistry and Biophysics, 780, 110777. https://doi.org/10.1016/j.abb.2026.110777

Vancouver

Li W, Liang X, Wu X, Zheng B, Cheng J. RHBDD1 promotes cervical cancer progression by activating the EGFR/PI3K/AKT signaling pathway. Archives of Biochemistry and Biophysics. 2026;780:110777. doi:10.1016/j.abb.2026.110777

BibTeX
@article{Li2026,
  author = {Li, Wei and Liang, Xin and Wu, Xiurong and Zheng, Bijuan and Cheng, Jie},
  title = {RHBDD1 promotes cervical cancer progression by activating the EGFR/PI3K/AKT signaling pathway},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2026},
  volume = {780},
  pages = {110777},
  doi = {10.1016/j.abb.2026.110777}
}
Kostenlos starten →